Navigation Links
Torchmark Prices Senior Notes Offering
Date:6/25/2009

MCKINNEY, Texas, June 25 /PRNewswire-FirstCall/ -- Torchmark Corporation (NYSE: TMK) announced today that it has priced an offering of $300 million in aggregate principal amount of 9.25% Senior Notes that will mature in 2019. Torchmark expects the offering to close on June 30, 2009, subject to the satisfaction of customary closing conditions. The net proceeds of the offering will be used for the repayment of the $99.45 million in aggregate principal amount of Torchmark's 8.25% Senior Debentures that mature on August 15, 2009, and general corporate purposes.

Wachovia Capital Markets, LLC and SunTrust Robinson Humphrey, Inc. are acting as joint book-running managers for the offering.

This press release does not constitute an offer to sell or the solicitation of an offer to buy any of the notes or any other securities, nor will there be any sale of the notes or any other securities in any jurisdiction in which such offer, solicitation or sale would be unlawful. The notes will be sold pursuant to Torchmark's effective shelf registration statement on file with the Securities and Exchange Commission.

The offering of the notes is being made only by means of a prospectus supplement and accompanying prospectus, copies of which may be obtained from:

    Wachovia Capital Markets, LLC
    c/o Wachovia Customer Information Center
    1525 West W.T. Harris Boulevard
    Charlotte, North Carolina 28262-0675
    Attention: Syndicate Operations
    1-800-326-5897

    SunTrust Robinson Humphrey, Inc.
    303 Peachtree Street, 24th Floor
    Mail Code: GA-ATLANTA-3947
    Atlanta, GA  30308
    Attention: Investment Grade Debt Capital Markets
    1-800-685-4786

Alternatively, the prospectus supplement and accompanying prospectus may be obtained by visiting the SEC's Web site at www.sec.gov.

Torchmark Corporation is a holding company specializing in life and supplemental health insurance for "middle income" Americans marketed through multiple distribution channels including direct response, and exclusive and independent agencies.

CAUTION REGARDING FORWARD-LOOKING STATEMENTS:

This press release contains certain statements that may be deemed to be "forward-looking statements" within the meaning of the federal securities laws. These forward-looking statements reflect management's current expectations, but are not guarantees of future performance. Accordingly, please refer to Torchmark's cautionary statement regarding forward-looking statements and the risks and uncertainties applicable to Torchmark's business that are contained in the Company's Form 10-K for the year ended December 31, 2008, and any subsequent Forms 10-Q or Forms 8-K on file with the Securities and Exchange Commission and on the Company's website at www.torchmarkcorp.com on the Investor Relations page. Torchmark specifically disclaims any obligation to update or revise any forward-looking statement because of new information, future developments or otherwise.


'/>"/>
SOURCE Torchmark Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. Torchmark Corporation Announces Change in Domicile State of Insurance Subsidiaries to Nebraska
2. Torchmark Corporation Announces Fourth Quarter 2007 Earnings Release and Conference Call
3. Torchmark Corporation to Present at Merrill Lynch Insurance Investors Conference
4. Torchmark Corporation Reports First Quarter 2008 Results
5. Torchmark Corporation Declares Dividend
6. Torchmark Corporation Declares Dividend
7. Torchmark Corporation Announces Fourth Quarter 2008 Earnings Release and Conference Call
8. Torchmark Corporation to Present at Merrill Lynch Insurance Investors Conference
9. Torchmark Corporation Reports First Quarter 2009 Results
10. Lincare Holdings Inc. Prices $500 Million Convertible Senior Debentures Offering
11. American Association for Homecare Disputes Validity of Internet Power Wheelchair Prices as Basis for Reimbursement of Services in Medicare
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/26/2016)... ... ... PawPaws brand pet supplements owned by Whole Health Supply is ... of felines. The formula is all-natural and is made from Chinese herbs that have ... Kidney Support Supplement Soft Chews are Astragalus Root Extract and Rehmannia Root Extract ...
(Date:6/25/2016)... ... ... Austin residents seeking Mohs surgery services, can now turn to Dr. Jessica ... Peckham for medical and surgical dermatology. , Dr. Dorsey brings specialization to include Mohs ... Mohs Micrographic Surgery completed by Dr. Dorsey was under the direction of Glenn Goldstein, ...
(Date:6/25/2016)... ... , ... As a lifelong Southern Californian, Dr. Omkar Marathe earned his Bachelors ... Geffen School of Medicine at UCLA. He trained in Internal Medicine at Scripps Green ... hematology/oncology at the UCLA-Olive View-Cedars Sinai program where he had the opportunity to train ...
(Date:6/24/2016)... ... 24, 2016 , ... A recent article published June 14 on ... article goes on to state that individuals are now more comfortable seeking to undergo ... such as calf and cheek reduction. The Los Angeles area medical group, Beverly Hills ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... -- Research and Markets has announced the addition ... 2022" report to their offering. ... with kidney failure, it replaces the function of kidneys by ... and thus the treatment helps to keep the patient body,s ... Increasing number of ESRD patients & substantial healthcare ...
(Date:6/23/2016)... Research and Markets has announced ... Type (Organic Chemical (Sugar, Petrochemical, Glycerin), Inorganic Chemical), Functionality ... - Global Forecast to 2021" report to their ... global pharmaceutical excipients market is projected to reach USD ... in the forecast period 2016 to 2021. ...
(Date:6/23/2016)... 23, 2016 Roche (SIX: RO, ROG; OTCQX: ... its Elecsys BRAHMS PCT (procalcitonin) assay as a dedicated ... shock. With this clearance, Roche is the first IVD ... solution for sepsis risk assessment and management. ... and PCT levels in blood can aid clinicians in ...
Breaking Medicine Technology: